Elsevier,
Translational Sports Medicine
Handbook for Designing and Conducting Clinical and Translational Research
2023, Pages 513-518
This chapter focuses on n the population and environmental considerations that impact how patients receive care, identify health concerns, and empower them to take initiative in their own care with the health teams surrounding their care supporting SDG 3.
Public policy and linked social action must address the structural or intermediary social determinants of health. Though policy decisions or reform is one of the social action approaches, the programmatic, regulatory, and community development approaches need to be efficiently used. The COVID-19 pandemic expedited and facilitated collaboration with people outside the health sector. Such established and better-performing collaborations and social actions need continuation and expansion to other areas for better health and well-being. The national and subnational multisectoral action plan and its effective implementation can facilitate the “Health in All Policies” and address most of the social determinants of health.
To ensure sustainability, vertical or disease-specific programs or projects (government funded or external funded) should not develop standalone community participation interventions. They should be mandated to build on the existing social capital. The untied funds required for implementation of decentralized decision-making should be released in a timely manner without needless audit objections. Communities are not going to go anywhere. Hence, we need consistence in policy concerning community participation and patience from the administrators to implement community participation holistically with realistic sustainable short-term process indicators, while the focus is on medium- and long-term goals, including SDG3.
Elsevier,
Psychosocial Experiences and Adjustment of Migrants, Coming to the USA. 2023, Pages 391-418
Ongoing attention must be paid to these psychological dimensions for migrants and refugees, as well as further research, de-stigmatization, and education of governments and other stakeholders during the Compacts' implementation, review, and follow-up period, supporting SDG3.
Elsevier,
Overcoming Obstacles in Drug Discovery and Development, Surmounting the Insurmountable—Case Studies for Critical Thinking 2023
Racial and ethnic disparities among clinical trial participants is a long-standing issue demanding attention in the research community as advances in precision medicine increase. This exclusion from clinical trial enrollment has tangible consequences, preventing traditionally underserved populations from benefitting from health innovation and cutting-edge technologies. Aggregation of populations into a generalized treatment population lends to the evident healthcare inequities we see today and support SDG3
This Article supports SDGs 3 and 10 by assessing predictors for COVID-19 vaccine uptake among older Syrian refugees in Lebanon and highlighting the need to target hard to reach populations to improve access and uptake.
This study shows that agricultural water consumption tends to use internal water resources at a maximum level for export and national use, significantly impacting renewable and non-renewable water resource availability, especially in groundwater.
Elsevier,
Principles of Gender-Specific Medicine (Fourth Edition)
Sex and Gender-Specific Biology in the Postgenomic Era
2023, Pages 409-429
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of gender-specific medicine in pharmaceutical development and global healthcare, aiming to improve health outcomes for all genders. By addressing the challenges faced by the pharmaceutical industry in integrating knowledge on sex-specific biological differences into drug development programs, the chapter advocates for strategies to promote equity in healthcare access and outcomes. Additionally, it recognizes the importance of addressing gender disparities in healthcare and advocating for approaches that ensure equal access to gender-specific pharmaceuticals. Through these efforts, the content supports the goal of reducing inequalities in healthcare access and outcomes, ultimately contributing to the promotion of good health and well-being for all individuals, regardless of gender.
One Health and the Exposome embrace a broad view of human health and its environmental drivers as well as provide various tools and modes of operation to systematically uncover pathways linking poor health outcomes with their root causes to inform interventions supporting the WHO SDG3.
Habitat conversion and resource utilization have been identified in the One Health approach as drivers of poor ecosystem health that can lead to disease spillover events supporting SDG3.
